placeholder
Importance
32
Trust
71
Urgency
30
The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances - Yahoo Finance
The Precision Peptide Company is moving toward selling a patch version of BPC-157 (a peptide used to help with healing) that doesn't need a needle. The company is finishing final tests before launching the product commercially.
Analysis
A small company is testing a patch form of BPC-157 that skips needles. No trial data or launch date is confirmed in the source.
- The Precision Peptide Company is developing a needle-free BPC-157 patch
- Product is in final testing before a planned commercial launch
Peptide Therapy Research1mo
Read